2024
P27.10.B FACTORS INFLUENCING TIMELY DIAGNOSIS IN NEUROLYMPHOMATOSIS
Doubrovinskaia S, Egert A, Karschnia P, Scheffler G, Huttner A, Fulbright R, Baehring J, Kaulen L. P27.10.B FACTORS INFLUENCING TIMELY DIAGNOSIS IN NEUROLYMPHOMATOSIS. Neuro-Oncology 2024, 26: v138-v139. PMCID: PMC11485484, DOI: 10.1093/neuonc/noae144.472.Peer-Reviewed Original ResearchNon-Hodgkin's lymphomaPeripheral nervous systemNerve root lesionsDiagnostic intervalRelapse of NHLSymptom onsetAssociated with early diagnosisTertiary referral centerAtypical clinical presentationRoot lesionsCerebrospinal fluid examinationDiagnostic work-upYale Cancer CenterPainful polyneuropathyAsymmetric neuropathyClinical presentationReferral centerFluid examinationQuality control databaseDiagnostic delayFDG-PETPrimary diseaseUnivariate analysisConventional CTNeurolymphomatosisFactors influencing timely diagnosis in neurolymphomatosis
Doubrovinskaia S, Egert A, Karschnia P, Scheffler G, Traub B, Galluzzo D, Huttner A, Fulbright R, Baehring J, Kaulen L. Factors influencing timely diagnosis in neurolymphomatosis. Journal Of Neuro-Oncology 2024, 170: 309-317. PMID: 39115616, DOI: 10.1007/s11060-024-04792-2.Peer-Reviewed Original ResearchNon-Hodgkin's lymphomaPeripheral nervous systemDiagnostic intervalNon-Hodgkin lymphoma diagnosisSymptom onset to diagnosisCerebrospinal fluid examinationYale Cancer CenterPainful polyneuropathyAsymmetric neuropathyRare entityMedian intervalFluid examinationQuality control databaseDelayed DiagnosisPrimary diseaseUnivariate analysisConventional CTDisease sitesNeurolymphomatosisNeuro-oncologyCancer CenterSecondary diseaseImaging modalitiesNeuroimaging findingsDiagnosis
2012
Safety and biomarker effects of solanezumab in patients with Alzheimer's disease
Farlow M, Arnold SE, van Dyck C, Aisen PS, Snider BJ, Porsteinsson AP, Friedrich S, Dean RA, Gonzales C, Sethuraman G, DeMattos RB, Mohs R, Paul SM, Siemers ER. Safety and biomarker effects of solanezumab in patients with Alzheimer's disease. Alzheimer's & Dementia 2012, 8: 261-271. PMID: 22672770, DOI: 10.1016/j.jalz.2011.09.224.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAlzheimer DiseaseAmyloid beta-PeptidesAntibodies, Monoclonal, HumanizedCognition DisordersDose-Response Relationship, DrugDouble-Blind MethodElectroencephalographyEnzyme-Linked Immunosorbent AssayFemaleFollow-Up StudiesHumansMaleMiddle AgedNeuropsychological TestsPeptide FragmentsPsychiatric Status Rating ScalesPyridinesTomography, Emission-Computed, Single-PhotonTreatment OutcomeConceptsAlzheimer's Disease Assessment Scale-cognitive portionAntibody administrationDose-dependent mannerAlzheimer's diseaseAntibody treatmentAnti-β-amyloid antibodiesPlacebo-controlled clinical trialMagnetic resonance imaging (MRI) scansCerebrospinal fluid examinationClinical laboratory valuesActive treatment periodCSF cell countResonance imaging scansModerate Alzheimer's diseaseDose-dependent increaseMagnetic resonance imagingWeekly infusionsAdverse eventsFluid examinationImaging scansClinical trialsLaboratory valuesTreatment periodAmyloid plaquesCell count
2003
Mollaret's meningitis: Cytopathologic analysis of fourteen cases
Chan TY, Parwani AV, Levi AW, Ali SZ. Mollaret's meningitis: Cytopathologic analysis of fourteen cases. Diagnostic Cytopathology 2003, 28: 227-231. PMID: 12722116, DOI: 10.1002/dc.10261.Peer-Reviewed Original ResearchConceptsMollaret's meningitisRecurrent episodesPolymerase chain reactionPolymorphonuclear leukocytesMost common clinical presentationCerebrospinal fluid examinationCommon clinical presentationAppropriate clinical settingSmall mature lymphocytesHerpes simplex virus type 2 DNAHemosiderin-laden macrophagesCentral nervous systemVirus type 2 DNASole diagnostic modalityAseptic meningitisCSF examinationFluid examinationClinical presentationLymphoproliferative disordersMild feverClinical dataCytopathologic analysisDifferential diagnosisPlasma cellsDiagnostic modalities
1994
NEW DIAGNOSTIC TECHNIQUES IN THE EVALUATION OF ANATOMIC ABNORMALITIES OF THE INFERTILE MALE
Honig S. NEW DIAGNOSTIC TECHNIQUES IN THE EVALUATION OF ANATOMIC ABNORMALITIES OF THE INFERTILE MALE. Urologic Clinics Of North America 1994, 21: 417-432. PMID: 8059498, DOI: 10.1016/s0094-0143(21)00617-0.Peer-Reviewed Original ResearchConceptsMR imagingMale genital disordersInitial diagnostic testMale factor fertilityNew diagnostic imaging modalityDiagnostic imaging modalitiesMale reproductive systemNew diagnostic techniquesFluid examinationSuch patientsSurgical explorationImportant diagnostic toolAnatomic abnormalitiesDuctal anatomyDisease entityScrotal ultrasonographyGenital disordersDiagnostic maneuversBlood flowDisease processMale infertilityUseful adjunctInfertile malesTreatment planParatesticular structures
1988
Primary leptomeningeal sarcomatosis. Case report.
Thibodeau L, Ariza A, Piepmeier J. Primary leptomeningeal sarcomatosis. Case report. Journal Of Neurosurgery 1988, 68: 802-5. PMID: 3357038, DOI: 10.3171/jns.1988.68.5.0802.Peer-Reviewed Original ResearchConceptsCerebrospinal fluid examinationMultiple cranial nervesPrimary leptomeningeal sarcomatosisMeningeal diseaseFluid examinationSurgical explorationClinical evidenceOpen biopsyCase reportPathological diagnosisProgressive deficitsCranial nervesSpinal rootsInvasive methodBiopsyDiffuse processDiseaseDiagnosisReportSarcomatosisLeptomeningesPatientsNerve
1984
Candidal infection in the central nervous system
Lipton S, Hickey W, Morris J, Loscalzo J. Candidal infection in the central nervous system. The American Journal Of Medicine 1984, 76: 101-108. PMID: 6691350, DOI: 10.1016/0002-9343(84)90757-5.Peer-Reviewed Original ResearchConceptsMycotic aneurysmCandidal infectionAntemortem diagnosisAmphotericin BCentral nervous system involvementCentral nervous system candidiasisPercent of patientsCerebrospinal fluid examinationNervous system involvementCentral nervous systemCerebral mycosisInadequate eradicationMeningeal formCerebral involvementParenchymal infectionFluid examinationUnrecognized lesionsDrug therapySystem involvementCerebral vesselsFungus ballRisk factorsDisease entityEarly diagnosisSignificant incidence
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply